11 minute read
Jun. 10, 2022

Acceleron’s TGF-beta Ligand Trap, Trillium’s SIRP-alpha Fusion Proteins, and Eight Other Large Molecules Acquired in 2021

drughunter.com
Drug Hunter Team

Our team conducted a review of all of the biotech mergers and acquisitions of 2021 and distilled it down to the acquisitions of drug discovery-focused biotechs here. There were 10 acquisitions of companies with large molecule drug assets in 2021. Here is a more in-depth look into all of the lead large molecules acquired in 2021, including a review of: 

  • The financial details of the acquisition/merger

  • The mechanism of action and indication of each lead molecule

  • The stage of clinical development for each lead molecule

Drug Discovery Biotech M&As: Large Molecules Deep Dive (Part 6)

Loading...

twitterlinkedinemail

Other articles you may be interested in